Insider Transactions in Q2 2022 at Phreesia, Inc. (PHR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+16.74%
|
-
|
|
Jun 30
2022
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
581
+0.44%
|
$12,201
$21.26 P/Share
|
|
Jun 30
2022
|
Ramin Sayar Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+37.76%
|
-
|
|
Jun 30
2022
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+31.46%
|
-
|
|
Jun 30
2022
|
Michael Weintraub Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+4.07%
|
-
|
|
Jun 30
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+23.44%
|
-
|
|
Jun 30
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
245
+0.21%
|
$5,145
$21.26 P/Share
|
|
Jun 30
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+24.84%
|
-
|
|
Jun 24
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
5,046
-4.37%
|
$126,150
$25.11 P/Share
|
|
May 16
2022
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
2,106
-11.16%
|
$33,696
$16.06 P/Share
|
|
May 09
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
3,909
-1.11%
|
$66,453
$17.5 P/Share
|
|
May 09
2022
|
Gillian Munson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-7.13%
|
$23,184
$16.54 P/Share
|
|
Apr 30
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
952
-0.72%
|
$20,944
$22.88 P/Share
|
|
Apr 29
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
382
+1.28%
|
$8,404
$22.88 P/Share
|
|
Apr 29
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
382
+2.49%
|
$8,404
$22.88 P/Share
|
|
Apr 29
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
382
+1.85%
|
$8,404
$22.88 P/Share
|
|
Apr 14
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,128
-0.94%
|
$30,456
$27.63 P/Share
|
|
Apr 14
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-0.57%
|
$11,124
$27.63 P/Share
|
|
Apr 14
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-0.58%
|
$35,505
$27.63 P/Share
|
|
Apr 14
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-0.68%
|
$21,411
$27.63 P/Share
|
|
Apr 14
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.91%
|
$32,913
$27.63 P/Share
|
|
Apr 14
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-0.24%
|
$46,062
$27.63 P/Share
|
|
Apr 14
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,917
-0.23%
|
$78,759
$27.63 P/Share
|
|
Apr 13
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,098
-3.3%
|
$114,744
$28.73 P/Share
|
|
Apr 13
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,007
+6.05%
|
-
|
|
Apr 13
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
783
-1.07%
|
$21,924
$28.73 P/Share
|
|
Apr 13
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,669
+3.52%
|
-
|
|
Apr 13
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
2,254
-0.98%
|
$63,112
$28.73 P/Share
|
|
Apr 13
2022
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
9,253
+3.88%
|
-
|
|
Apr 13
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
2,053
-1.73%
|
$57,484
$28.73 P/Share
|
|
Apr 13
2022
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
5,694
+4.59%
|
-
|
|
Apr 13
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,376
-2.47%
|
$94,528
$28.73 P/Share
|
|
Apr 13
2022
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,253
+6.33%
|
-
|
|
Apr 13
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,724
-0.65%
|
$132,272
$28.73 P/Share
|
|
Apr 13
2022
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,253
+1.26%
|
-
|
|
Apr 13
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,357
-0.74%
|
$261,996
$28.73 P/Share
|
|
Apr 13
2022
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,328
+1.44%
|
-
|